Literature DB >> 22032526

Alcohol and substance use in liver transplant patients.

Andrea DiMartini1, Catherine Crone, Mary Amanda Dew.   

Abstract

In this article the epidemiology of substance use and substance disorders in the United States and their association with liver disease are reviewed. The relevance of tobacco use and issues of candidacy as it pertains to substance use are discussed. The use of alcohol while on the waitlist and short sobriety are also addressed. The merits of monitoring of patients are discussed, and the outcomes of these patients after liver transplantation are examined. The article concludes with a summary of recommendations for clinicians working with these patients and possible future directions for both clinical care and research.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22032526     DOI: 10.1016/j.cld.2011.08.002

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  11 in total

1.  History of Marijuana Use Does Not Affect Outcomes on the Liver Transplant Waitlist.

Authors:  Prashant Kotwani; Varun Saxena; Jennifer L Dodge; John Roberts; Francis Yao; Bilal Hameed
Journal:  Transplantation       Date:  2018-05       Impact factor: 4.939

Review 2.  Biomarkers for detection of alcohol consumption in liver transplantation.

Authors:  Katharina Staufer; Michel Yegles
Journal:  World J Gastroenterol       Date:  2016-04-14       Impact factor: 5.742

Review 3.  Ethical issues associated with solid organ transplantation and substance use: a scoping review.

Authors:  Lauren Notini; Denitsa Vasileva; Ani Orchanian-Cheff; Daniel Z Buchman
Journal:  Monash Bioeth Rev       Date:  2019-12

Review 4.  Ethical and allocation issues in liver transplant candidates with alcohol related liver disease.

Authors:  Mai Sedki; Aijaz Ahmed; Aparna Goel
Journal:  Transl Gastroenterol Hepatol       Date:  2022-07-25

5.  Resilience in Organ Transplantation: An Application of the Connor-Davidson Resilience Scale (CD-RISC) With Liver Transplant Candidates.

Authors:  Anne C Fernandez; Dwain C Fehon; Hayley Treloar; Reuben Ng; William H Sledge
Journal:  J Pers Assess       Date:  2015-04-27

Review 6.  Challenges in transplantation for alcoholic liver disease.

Authors:  Gabriela A Berlakovich
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

7.  Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis.

Authors:  Shari Rogal; Ada Youk; Olufunso Agbalajobi; Hongwei Zhang; Walid Gellad; Michael J Fine; Pamela Belperio; Timothy Morgan; Chester B Good; Kevin Kraemer
Journal:  Am J Gastroenterol       Date:  2021-07-01       Impact factor: 12.045

8.  Indications for liver transplantation in adults : Recommendations of the Austrian Society for Gastroenterology and Hepatology (ÖGGH) in cooperation with the Austrian Society for Transplantation, Transfusion and Genetics (ATX).

Authors:  Ivo Graziadei; Heinz Zoller; Peter Fickert; Stefan Schneeberger; Armin Finkenstedt; Markus Peck-Radosavljevic; Helmut Müller; Claudia Kohl; Barbara Sperner-Unterweger; Stephan Eschertzhuber; Harald Hofer; Dietmar Öfner; Herbert Tilg; Wolfgang Vogel; Michael Trauner; Gabriela Berlakovich
Journal:  Wien Klin Wochenschr       Date:  2016-09-02       Impact factor: 1.704

9.  Risk factors for hospitalizations among patients with cirrhosis: A prospective cohort study.

Authors:  Shari S Rogal; Viyan Udawatta; Imo Akpan; Akshata Moghe; Alexis Chidi; Amit Shetty; Eva Szigethy; Klaus Bielefeldt; Andrea DiMartini
Journal:  PLoS One       Date:  2017-11-17       Impact factor: 3.240

Review 10.  2020 Clinical Update in Liver Transplantation.

Authors:  Trevor J Wilke; Bradley A Fremming; Brittany A Brown; Nicholas W Markin; Cale A Kassel
Journal:  J Cardiothorac Vasc Anesth       Date:  2021-02-06       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.